View All Key Stats
ISR Key Stats
| Income Statement | |
| Revenue (TTM) | 5.69M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -0.1164 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -6.196M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 38.72% |
| Profit Margin (Quarterly) | -84.68% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | Upgrade |
| Price and Valuation | |
| Market Cap | 33.61M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 5.902 |
| PE Ratio (TTM) | -- |
| Price to Book Value | 5.080 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | Upgrade |
| Free Cash Flow (Quarterly) | -1.311M |
| Return on Equity (TTM) | Upgrade |
View All ISR News
ISR News
-
WireHeadlineTime (ET)
-
MT Newswires07/12 08:46
-
Globe Newswire07/12 08:30
-
MT Newswires07/10 16:26
-
SA Breaking News07/10 12:52
-
MT Newswires07/10 12:41
-
SA Breaking News07/10 11:00
-
SA Breaking News07/10 10:15
-
PR Newswire07/10 09:31
-
SA Breaking News07/10 09:25
-
Yahoo07/10 09:21
View All Events
ISR Events
| Date | Type | Description |
|---|---|---|
| 11/14/2018 16:30 EDT | Misc | IsoRay Inc First Quarter Earnings Conference Call in 2019 |
| 02/08/2018 | Earnings | IsoRay Inc Second Quarter Earnings Results in 2018 |
| 11/14/2017 16:30 EDT | Misc | IsoRay Inc First Quarter Earnings Conference Call in 2018 |
| 11/14/2017 | Earnings | IsoRay Inc First Quarter Earnings in 2018 Release |
| 08/04/2017 | Earnings | IsoRay Inc Fourth Quarter Earnings Results in 2017 |
ISR Fundamentals
Income Statement View Statement
ISR Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
ISR One Page Reports
- One Page Report Download
ISR Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 0.61 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Edit
Profile
- URL: http://www.isoray.com
- Investor Relations URL: https://isoray.com/about/investors/
- HQ State/Province: Washington
- Sector: Healthcare
- Industry: Medical Instruments & Supplies
- Equity Style: Small Cap/Blend
- Next Earnings Release: N/A
- Last Earnings Release: Feb. 08, 2018
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: IsoRay Inc designs and develops personalized brachytherapy products. The company treats prostate cancer, brain, liver, breast cancer, colorectal cancer, gynecological cancer, lung cancer, ocular melanoma and pancreatic cancer.
ISR Excel Add-In Codes
- Name: =YCI("ISR","name")
- Description: =YCI("ISR","description")
- Sector: =YCI("ISR","sector")
- Industry: =YCI("ISR","industry")
- Est. Current Fiscal Year End: =YCI("ISR","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other ISR Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- ISR Tweets Stocktwits
Advertisement
